BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 34061831)

  • 1. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 May; 397(10285):1625-1636. PubMed ID: 33933205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2021 Sep; 398(10305):1053-1064. PubMed ID: 34461040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.
    Karmali KN; Lloyd-Jones DM; van der Leeuw J; Goff DC; Yusuf S; Zanchetti A; Glasziou P; Jackson R; Woodward M; Rodgers A; Neal BC; Berge E; Teo K; Davis BR; Chalmers J; Pepine C; Rahimi K; Sundström J;
    PLoS Med; 2018 Mar; 15(3):e1002538. PubMed ID: 29558462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2285-95. PubMed ID: 25255397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
    Law MR; Morris JK; Wald NJ
    BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
    Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
    Neal B; MacMahon S; Chapman N;
    Lancet; 2000 Dec; 356(9246):1955-64. PubMed ID: 11130523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Aug; 34(8):1451-63. PubMed ID: 27228434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial.
    Jiang C; Lai Y; Du X; Wang Y; Li S; He L; Hu R; Lv Q; Wu J; Feng L; Ning M; Ruan Y; Li X; Jia C; Dai W; Guo X; Jiang C; Tang R; Sang C; Long D; Arima H; Dong J; Anderson CS; Ma C
    Europace; 2022 Oct; 24(10):1560-1568. PubMed ID: 35640916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis.
    Bidel Z; Nazarzadeh M; Canoy D; Copland E; Gerdts E; Woodward M; Gupta AK; Reid CM; Cushman WC; Wachtell K; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    Hypertension; 2023 Nov; 80(11):2293-2302. PubMed ID: 37485657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis.
    Sundström J; Arima H; Jackson R; Turnbull F; Rahimi K; Chalmers J; Woodward M; Neal B;
    Ann Intern Med; 2015 Feb; 162(3):184-91. PubMed ID: 25531552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
    Blood Pressure Lowering Treatment Trialists' Collaboration
    Lancet; 2014 Aug; 384(9943):591-598. PubMed ID: 25131978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.